Manabu Muto

23PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTime-series analysisInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 07, 2026
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

|Feb 04, 2026
Real-world characterization of patients with advanced or metastatic liposarcoma, including dedifferentiated liposarcoma, in Japan in the MASTER KEY project.

Hitomi Sumiyoshi Okuma, Kenji Tsuchihashi, Eishi Baba

|Jan 16, 2026
Treatment resistance factors associated with Talaporfin sodium photodynamic therapy for local control after chemoradiotherapy for esophageal cancer.

Masashi Tamaoki, Akira Yokoyama, Chikatoshi Katada

|Nov 11, 2025
Long-term outcome of PDT for local failure after CRT or RT for oesophageal cancer.

Takahiro Horimatsu, Tomonori Yano, Yoshinobu Yamamoto

|Apr 30, 2025
Somatic mosaicism in the buccal mucosa reflects lifestyle and germline risk factors for esophageal squamous cell carcinoma.

Akira Yokoyama, Koichi Watanabe, Yoshikage Inoue

|Apr 12, 2025
First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors: 1-Year Follow-Up of the FIRST-Dx Study.

Junichi Matsubara, Kumi Mukai, Tomohiro Kondo

Pageof 4

Frequent Collaborators

4 joint publications

Tomohiro Kondo

4 joint publications

Chikatoshi Katada

3 joint publications

Hidenori Kage

3 joint publications

Hidekazu Shirota